Prepared For

Ms Rina Saha
F 82
fa lse

Name Gender Your Health Summary

Ms Rina Saha F Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
12415988 82 View Detailed Summary on our App

Health Summary

THYROID PROFILE

Everything looks good

DIABETES MONITORING
LIPID PROFILE

Test Name Result

Test Name Result
Glycosylated Hemoglobin (HbA1c) 6.7
Triglycerides 154.3
Glucose Fasting 114.6
Please Watchout

Please Watchout

KIDNEY PROFILE
LIVER PROFILE
Everything looks good
Everything looks good

MINERAL PROFILE

Everything looks good

 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 25869998
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 03:14 PM.
Test Description Value(s) Unit(s) Reference Range

Diabetes Profile- Essential

HbA1C (Glycosylated Haemoglobin)

Glycosylated Hemoglobin (HbA1c) 6.7 % < 5.7

HPLC
Estimated Average Glucose 145.59

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high
concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular disease. In patients with
significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood
and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 11ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26306666
Referred BY : Self Sample Type : FLUORIDE F
....

Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:40 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting

Glucose Fasting 114.6 mg/dL 70 - <100

Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 22ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26306620
Referred BY : Self Sample Type : FLUORIDE PP
....

Sample Collected : May 13, 2025, 11:27 AM Report Date : May 13, 2025, 02:40 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose Post Prandial

Glucose Post Prandial 120.1 mg/dL 70 - 140

(Fluoride Plasma-P,Hexokinase)

Interpretation:
Status PP plasma glucose in mg/dL
Normal <140
Impaired glucose tolerance 140 - 199
Diabetes =>200

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 33ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26474973
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:41 PM.
Test Description Value(s) Unit(s) Reference Range

Liver Function Test (LFT)

Bilirubin Total 0.3 mg/dL 0.2 - 1.2

Photometric
Bilirubin Direct * 0.2 mg/dL 0.0 - 0.5
Diazo Reaction
Bilirubin Indirect * 0.1 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 24.4 U/L 5 - 34
IFCC without P5P
SGPT/ALT 24.9 U/L 0 to 55
IFCC without P5P
SGOT/SGPT Ratio * 0.98 - -
Alkaline Phosphatase 91 U/L 40 - 150
p-nitrophenyl Phosphate, AMP buffer
Total Protein 6.8 g/dL 6.4 - 8.3
Biuret
Albumin 3.9 gm/dL 3.8 - 5.0
BCG
Globulin * 2.9 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.34 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 21.8 U/L 12 - 64
ENZYMATIC

Interpretation:
The liver filters blood, metabolizes nutrients, detoxifies harmful substances, and produces blood clotting proteins. Liver cells contain enzymes that facilitate
these functions. When cells are damaged, enzymes leak into the blood, detectable through blood tests.

Key enzymes tested:

1. AST (SGOT): may indicate tissue injury / damage in muscles or liver.

2. ALT (SGPT): Primarily in the liver. Elevated ALT and AST suggest liver damage.
3. Alkaline Phosphatase & GGT: Linked to bile production and flow. Elevated levels may indicate bile flow issues related to the liver, gallbladder, or bile ducts.

Blood proteins, albumin and globulin, are essential for growth, development, and health.

1. Low protein: May indicate bleeding, liver disorders, malnutrition, or agammaglobulinemia.

2. High protein (Hyperproteinemia): Often due to dehydration or increased protein production.
3. Low albumin: Caused by poor diet, kidney, or liver disease.
4. High albumin: Usually due to severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 44ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26474973
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:41 PM.
Test Description Value(s) Unit(s) Reference Range

Kidney Function Test (KFT)

Blood Urea 21.8 mg/dL 18 - 55

Modified Jaffe
Bun * 10.19 mg/dL 9.8 - 20.1
Urease
Creatinine 1 mg/dL 0.72 - 1.25
Modified Jaffe
eGFR (CKD-EPI) 56.23 ml/min/1.73 sq m Normal Or High: >= 90

Mild Or Decrease: 60-89

Mild To Moderate Decrease:

45-59

Mild To Severe Decrease:

30-44

Severe Decrease: 15-29

Kidney Failure: < 15

Bun/Creatinine Ratio * 10.19 12 - 20
Calculated
Urea / Creatinine Ratio * 21.8 25.68- 42.8
Calculated
Uric Acid 4.4 mg/dL 2.6 - 6.0
Uricase
Calcium Serum 9.9 mg/dL 8.8 - 10.0
O-Cresolphthalein Complex
Phosphorus 2.5 mg/dL 2.3 - 4.7
Colorimetric - Phosphomolybdate Formation
Sodium 142.2 mmol/L 136 - 145
Direct ISE
Potassium 3.4 mmol/L 3.5 - 5.1
Direct ISE
Chloride 100.8 mmol/L 98 - 107
Direct ISE

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual (chronic)
declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may indicate a problem with
your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful urination,swelling in the hands and feet
due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these symptoms suggest that your
kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes are present in the human body and the balancing act of the
electrolytes in our bodies is essential for normal function of our cells and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or
parathyroid disease. The test may also be done to monitor progress and treatment of these diseases.
"eGFR test is applicable for patients aged 18 years or more."

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 55ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26474973
Referred BY : Self Sample Type : Serum
Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:41 PM.
Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 66ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26474973
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:41 PM.
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 145 mg/dL <200

Enzymatic - Cholesterol Oxidase
Triglycerides 154.3 mg/dL <150
Colorimetric - Lip/Glycerol Kinase
HDL Cholesterol 40.0 mg/dL >40
Accelerator Selective Detergent
Non HDL Cholesterol * 105 mg/dL <130
Calculated
LDL Cholesterol * 74.14 mg/dL <100
Calculated
V.L.D.L Cholesterol * 30.86 mg/dL < 30
Calculated
Chol/HDL Ratio * 3.63 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.54 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 1.85 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130

Above Optimal 100-129 130 - 159

Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 77ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26474973
Referred BY : Self Sample Type : Serum
Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:41 PM.
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors
Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors
1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 88ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26474973
Referred BY : Self Sample Type : Serum
....

Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:41 PM.
Test Description Value(s) Unit(s) Reference Range

Thyroid Profile Total

Triiodothyronine (T3) 140 ng/dL 35 - 193

CLIA
Total Thyroxine (T4) 7.97 µg/dL 4.87 - 11.2
CLIA
Thyroid Stimulating Hormone (Ultrasensitive) 3.5 mIU/L 0.35 - 4.94
CMIA

Interpretation:
Pregnancy Refrence Range TSH
1st Trimester 0 .1 - 2.5
2nd Trimester 0.2 - 3.0
3rd Trimester 0.3 - 3.0

Clinical Use:
1. Diagnose Hypothyroidism & Hyperthyroidism
2. Monitor T4 therapy
3. Measure subnormal TSH levels

Increased TSH: Primary hypothyroidism, Subclinical hypothyroidism, TSH-dependent hyperthyroidism, Thyroid hormone resistance
Decreased TSH: Graves’ disease, Autonomous thyroid hormone secretion, TSH deficiency

Thyroid malfunction (hyper or hypo) affects T3 & T4 levels. Pituitary or hypothalamic issues also influence thyroid activity.

1. Primary Hypothyroidism: High TSH levels.

2. Secondary/Tertiary Hypothyroidism: Low TSH levels.
3. Euthyroid Sick Syndrome: Abnormal thyroid test results due to non-thyroidal illnesses (NTI).

TBG levels are stable in healthy individuals but may be altered by pregnancy, estrogens, androgens, steroids, or glucocorticoids, causing inaccurate T3 & T4
readings.

TSH T4 T3 Interpretation
High Normal Normal Mild (subclinical) hypothyroidism
High Low Low Or Nomral Hypothyroidism
Low Normal Normal Mild (subclinical) hyperthyroidism
Low High Or Normal High Or Normal Hyperthyroidism
Low Low Or Normal Low Or Normal Nonthyroidal illness; pituitary (secondary) hypothyroidism
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone
Normal High High
receptor decreases thyroid hormone function)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page
Page 99ofof12
13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 26474973
Referred BY : Self Sample Type : Serum
Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:41 PM.
Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page 10ofof12
Page 10 13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 104194932
Referred BY : Self Sample Type : Spot Urine
....

Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:26 PM.
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume * 20 ml -
Colour * Pale yellow - Pale yellow
Transparency * Clear - Clear
Deposit * Absent - Absent
Chemical Examination
Reaction (pH) 6.0 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.010 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Oxidase / Peroxidase
Urine Protein (Albumin) Positive(+) - Negative
Acid / Base Colour Excahnge
Urine Ketones (Acetone) Negative - Negative
Legals Test
Blood Negative - Negative
Peroxidase Hemoglobin
Leucocyte esterase Negative - Negative
Enzymatic Reaction
Bilirubin Urine Negative - Negative
Coupling Reaction
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) * 2-3 /hpf 0-5
Epithelial Cells * 1-2 /hpf 0-4
Red blood Cells * Absent /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria * Absent - Absent
Protozoa * Absent - Absent

Interpretation:
URINALYSIS- Routine urine analysis assists in screening and diagnosis of various metabolic, urological, kidney and liver disorders.

Protein: Elevated proteins can be an early sign of kidney disease. Urinary protein excretion can also be temporarily elevated by strenuous
exercise, orthostatic proteinuria, dehydration, urinary tract infections and acute illness with fever

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page 11ofof12
Page 11 13
 Patient NAME : Ms Rina Saha
DOB/Age/Gender : 82 Y/Female Report STATUS : Final Report
Patient ID / UHID : 12415988/RCL11741715 Barcode NO : 104194932
Referred BY : Self Sample Type : Spot Urine
Sample Collected : May 13, 2025, 11:26 AM Report Date : May 13, 2025, 02:26 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose: Uncontrolled diabetes mellitus can lead to presence of glucose in urine. Other causes include pregnancy, hormonal disturbances,
liver disease and certain medications.

Ketones: Uncontrolled diabetes mellitus can lead to presence of ketones in urine. Ketones can also be seen in starvation, frequent vomiting,
pregnancy and strenuous exercise.

Blood: Occult blood can occur in urine as intact erythrocytes or haemoglobin, which can occur in various urological, nephrological and
bleeding disorders.

Leukocytes: An increase in leukocytes is an indication of inflammation in urinary tract or kidneys. Most common cause is bacterial urinary tract
infection.

Nitrite: Many bacteria give positive results when their number is high. Nitrite concentration during infection increases with length of time the
urine specimen is retained in bladder prior to collection.

pH: The kidneys play an important role in maintaining acid base balance of the body. Conditions of the body producing acidosis/ alkalosis or
ingestion of certain type of food can affect the pH of urine.

Specific gravity: Specific gravity gives an indication of how concentrated the urine is. Increased specific gravity is seen in conditions like
dehydration, glycosuria and proteinuria while decreased specific gravity is seen in excessive fluid intake, renal failure and diabetes insipidus.

Bilirubin: In certain liver diseases such as biliary obstruction or hepatitis, bilirubin gets excreted in urine.

Urobilinogen: Positive results are seen in liver diseases like hepatitis and cirrhosis and in cases of haemolytic anaemia.

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Medicaids Pathological Lab & X-Ray Clinic, 6 IGM Hospital Lane
Rabindra Palli Agartala - 799001

Page 12ofof12
Page 12 13
 ADPL HBA1c Graph Report

Name : Sample Id : 25869998

Sample Type : Whole Blood EDTA
Total Area :
10.125

Peak Name Retention Time(s) Absorbance Area Result (Area %)

HbA0 69 0.1633 9.123 90.2

HbA1c 41 0.0052 0.676 6.7
La1c 39 0.0052 0.102 1.0
HbF 22 0.0018 0.096 0.9
Hba1b 16 0.0022 0.093 0.9
Hba1a 12 0.0011 0.035 0.3

Page 13 of 13
fa lse

Name Gender Your Health Summary

Ms Rina Saha F Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
12415988 82 View Detailed Summary on our App

Health Advisory
Normal (N) Low (L) Borderline (BL) High (H)

Diabetes
This panel is used to check how much glucose/sugar there is in your blood. Too much blood glucose might
indicate diabetes.

Glycosylated Hemoglobin (HbA1c): 6.7 % HIGH

HbA1c is your average blood glucose (sugar) levels for the past three months.

NORMAL BORDERLINE HIGH

< 5.7 5.7-6.4 > 6.4

You: 6.7

High HbA1c indicates: :

Average of blood glucose level in the last 2-3 months is abnormally high.

Glucose Fasting: 114.6 mg/dL HIGH

The amount of glucose in your blood continuously changes - it sometimes goes up and sometimes comes down. But
that depends on a lot of things. For example, your food timings affect the amount of glucose. That is why fasting is
required for this test.

LOW NORMAL HIGH

< 70 70-99 > 99

You: 114

Symptoms :

Increased thirst and frequent

Extreme hunger Unexplained weight loss
urination
fa lse

Lipid Profile
A panel of tests that measures the amount of fat or lipid in your blood.

Triglycerides: 154.3 mg/dL HIGH

The most common type of fat stored in your body. Triglycerides rise in your blood after you have a meal - as your body
converts energy that is not needed right away - into fat.

NORMAL HIGH

< 150 > 150

You: 154

Abnormal results may indicate :

High triglyceride levels increase your risk of heart, vascular disease. metabolic syndrome and stroke.
SMART HEALTH REPORT
RT

About Redcliffe Labs

We are India’s Most Trusted & Fastest Growing Network of Diagnostics Labs
Best Customer 100% Best Prices With
Experience Report Correctness Fast Reports

Commitment to excellence, Focus on quality with Value for money with

high end technology oriented staff accurate results quick turn around time (TAT)

For every 10,000 patients served,

we plant a tree

Select from a wide range of

Full Body Health Check-up
packages that suits your health

Best Selling Package

Annual Health Checkup

Advance Plus with Free HsCRP

Get free report consultation

& download our app

A Simple and easy way to track your health

3600 + Tests & Packages Presence in 220+ Cities

45 Min Express Sample 100% Accurate Report

Collection Guarantee.